ArticleNature neuroscience2019

In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer's disease.

Hanseul Park et al.PubMed ↗Publisher ↗

No numbers read from the abstract.